TGFB1 and idiopathic pulmonary fibrosis: Evaluation of the utility of inhibition of αvβ6-mediated TGFβ activation in SSc ILD, particularly the UIP and fibrotic NSIP subgroups, may be worth considering, especially if these early studies in IPF prove promising.